SCHEMBL3238250

SCHEMBL3238250

NC(=O)CCCCCC(=O)N(c1cccnc1)c1cc(-c2ccccc2)ccc1O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 6/20 0.41
▸ MKNK1 Q9BUB5 6/20 0.40
▸ MKNK2 Q9HBH9 6/20 0.40
▸ TBXAS1 P24557 1/20 0.39
▸ HDAC3 O15379 3/20 0.39
▸ LTB4R Q15722 1/20 0.36
▸ HDAC2 Q92769 2/20 0.36
▸ HDAC6 Q9UBN7 2/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ ERN1 O75460 1/20 0.36
▸ F10 P00742 1/20 0.36
▸ PRSS1 P07477 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3240810 0.87 ACMSD (0.39) HDAC1HDAC3LTB4RHDAC2HDAC6
SCHEMBL28253512 0.79 TBXAS1 (0.47) HDAC1TBXAS1HDAC3HDAC2HDAC6
SCHEMBL20591107 0.72 TBXAS1 (0.45) HDAC1TBXAS1HDAC3HDAC2HDAC6
SCHEMBL3236466 0.71 HDAC1 (0.41) HDAC1HDAC3LTB4RHDAC2HDAC6
SCHEMBL1769746 0.69 NPSR1 (0.53) HDAC1HDAC3HDAC2HDAC6HDAC4
SCHEMBL10596450 0.69 NPSR1 (0.53) HDAC1HDAC3HDAC2HDAC6HDAC4
SCHEMBL3236989 0.69 HDAC1 (0.38) HDAC1HDAC3LTB4RHDAC2HDAC6
SCHEMBL4138868 0.68 NPSR1 (0.55) —
SCHEMBL3242812 0.67 ALDH1A1 (0.40) HDAC1HDAC3HDAC2HDAC6HDAC4
SCHEMBL16369620 0.67 ALDH1A1 (0.40) HDAC1HDAC3HDAC2HDAC6HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 — — WO disclosed
Send feedback